Supplemental material
Drug Delivery
Volume 25, 2018 - Issue 1
Research Article
New model of proliferative vitreoretinopathy in rabbit for drug delivery and pharmacodynamic studies
, , , 
, , & show all
Kristyn HuffmanDepartment of Ophthalmology, Jacobs Retina Center at Shiley Eye Institute, University of California San Diego, La Jolla, CA, USA; http://orcid.org/0000-0002-3271-2518View further author information
http://orcid.org/0000-0002-3271-2518View further author information, , & Lingyun ChengDepartment of Ophthalmology, Jacobs Retina Center at Shiley Eye Institute, University of California San Diego, La Jolla, CA, USA; Correspondence[email protected]
http://orcid.org/0000-0002-0748-5173View further author information
http://orcid.org/0000-0002-0748-5173View further author information show allRelated Research Data
Correlation between different gene expression assays designed to measure trans-activation potencies of systemic glucocorticoids
Source:
Elsevier BV
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.
Source:
Elsevier BV
Verteporfin Photodynamic Therapy of Choroidal Neovascularization in Angioid Streaks
Source:
Elsevier BV
New model of proliferative vitreoretinopathy in rabbit for drug delivery and pharmacodynamic studies
Source:
Taylor & Francis
A Novel Approach of Daunorubicin Application on Formation of Proliferative Retinopathy Using a Porous Silicon Controlled Delivery System: Pharmacodynamics
Source:
Association for Research in Vision and Ophthalmology (ARVO)
The effect of triamcinolone acetonide or bevacizumab on the levels of proinflammatory cytokines after retinal laser photocoagulation in pigmented rabbits
Source:
Elsevier BV
Time-course of experimental choroidal neovascularization in Dutch-Belted rabbit: clinical and histological evaluation
Source:
Elsevier BV
Controlled Release of Dexamethasone From an Intravitreal Delivery System Using Porous Silicon Dioxide
Source:
Association for Research in Vision and Ophthalmology (ARVO)
Slow-Release Dexamethasone in Proliferative Vitreoretinopathy: A Prospective, Randomized Controlled Clinical Trial.
Source:
Elsevier BV
Postnatal Developmental Changes of Vitreous and Lens Volumes in Sprague-Dawley Rats
Source:
S. Karger AG
A randomized clinical trial comparing fixed vs pro-re-nata dosing of Ozurdex in refractory diabetic macular oedema (OZDRY study)
Source:
Springer Nature
New model of proliferative vitreoretinopathy in rabbit for drug delivery and pharmacodynamic studies
Source:
Taylor & Francis
Anterior chamber migration of dexametasone intravitreal implant (Ozurdex®)
Source:
Springer Nature
Tunable sustained intravitreal drug delivery system for daunorubicin using oxidized porous silicon
Source:
Elsevier BV
Preventive Versus Treatment Effect of Ag3340, a Potent Matrix Metalloproteinase Inhibitor in a Rat Model of Choroidal Neovascularization
Source:
Mary Ann Liebert Inc
In vivo models of proliferative vitreoretinopathy
Source:
Springer Science and Business Media LLC
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.
Source:
Elsevier BV
Pharmacokinetics and Pharmacodynamics of a Sustained-Release Dexamethasone Intravitreal Implant
Source:
Association for Research in Vision and Ophthalmology (ARVO)
Differential association of elevated inflammatory cytokines with postoperative fibrous proliferation and neovascularization after unsuccessful vitrectomy in eyes with proliferative diabetic retinopathy
Source:
Informa UK Limited
New model of proliferative vitreoretinopathy in rabbit for drug delivery and pharmacodynamic studies
Source:
Taylor & Francis
A new model of experimental subretinal neovascularization in the rabbit
Source:
Elsevier BV
A Novel Technique for Repositioning of a Migrated ILUVIEN® (Fluocinolone Acetonide) Implant into the Anterior Chamber
Source:
Springer Nature
Animal models of choroidal and retinal neovascularization.
Source:
Elsevier BV
Intravitreal Crystalline Drug Delivery for Intraocular Proliferation Diseases
Source:
Association for Research in Vision and Ophthalmology (ARVO)
The Intraocular Cytokine Profile and Therapeutic Response in Persistent Neovascular Age-Related Macular Degeneration
Source:
Association for Research in Vision and Ophthalmology (ARVO)
Intravitreal controlled release of dexamethasone from engineered microparticles of porous silicon dioxide
Source:
Elsevier BV
Secondary Glaucoma After Intravitreal Dexamethasone 0.7 mg Implant in Patients with Retinal Vein Occlusion: A One-Year Follow-Up
Source:
Mary Ann Liebert Inc
Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema
Source:
American Medical Association (AMA)
Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
Source:
American Medical Association (AMA)
Onset and recurrence of proliferative vitreoretinopathy in various vitreoretinal disease.
Source:
BMJ
Linking provided by
